Complexed prostate-specific antigen, and complext prostate- specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 20 and 40 ng/ml
Reissigl, A.; Remzi, M.; Wiunig, C.; Zlotta, A.; Ravery, V.; Hammerer, P.; Dobronski, P.; Kaisary, A.; Marberger, M.; Djavan, B.
Journal of Urology 169(4 Suppl): 426-427
2003
ISSN/ISBN: 0022-5347 Accession: 034627997
PDF emailed within 1 workday: $29.90
Related References
Morote, J.; Raventós, C.X.; Lorente, J.A.; Lopez-Pacios, M.A.; Encabo, G.; de Torres, I.; Andreu, J. 1997: Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml Journal of Urology 158(2): 502-504Auprich, M.; Augustin, H.; Budäus, L.; Kluth, L.; Mannweiler, S.; Shariat, S.F.; Fisch, M.; Graefen, M.; Pummer, K.; Chun, F.K.-H. 2012: A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy Bju International 109(11): 1627-1635
Ellis, W.J.; Etzioni, R.; Vessella, R.L.; Hu, C.; Goodman, G.E. 2001: Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer Journal of Urology 166(1): 93
Lein, M.; Jung, K.; Elgeti, U.; Petras, T.; Stephan, C.; Brux, B.; Sinha, P.; Winkelmann, B.; Schnorr, D.; Loening, S. 2001: Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis European Urology 39(1): 57-64
Chiang, I.-N.; Chang, S.-J.; Pu, Y.-S.; Huang, K.-H.; Yu, H.-J.; Huang, C.-Y. 2009: Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection Urologia Internationalis 82(3): 270-275
Catalona, W.J.; Partin, A.W.; Sanda, M.G.; Wei, J.T.; Klee, G.G.; Bangma, C.H.; Slawin, K.M.; Marks, L.S.; Loeb, S.; Broyles, D.L.; Shin, S.S.; Cruz, A.B.; Chan, D.W.; Sokoll, L.J.; Roberts, W.L.; van Schaik, R.H.N.; Mizrahi, I.A. 2011: A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range Journal of Urology 185(5): 1650-1655
Horninger, W.; Cheli, C.D.; Babaian, R.J.; Fritsche, H.A.; Lepor, H.; Taneja, S.S.; Childs, S.; Stamey, T.A.; Sokoll, L.J.; Chan, D.W.; Brawer, M.K.; Partin, A.W.; Bartsch, G. 2002: Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter Urology 60(4 Suppl 1): 31-35
Sedmak, B.; Trsinar, B.; Homan, G. 2000: Indirectly determined complexed prostate specific antigen and new parameter Complexed prostate specific antigen density for early detection of prostate cancer Journal of Endourology 14(Suppl 1): A22
Okihara, K.; Fritsche, H.A.; Ayala, A.; Johnston, D.A.; Allard, W.J.; Babaian, R.J. 2001: Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml Journal of Urology 165(6 Pt 1): 1930-1936
Catalona, W.J.; Bartsch, G.; Rittenhouse, H.G.; Evans, C.L.; Linton, H.J.; Amirkhan, A.; Horninger, W.; Klocker, H.; Mikolajczyk, S.D. 2003: Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml Journal of Urology 170(6 Part 1): 2181-2185
Yamamoto, S.; Maruyama, T.; Kondoh, N.; Nojima, M.; Takiuchi, H.; Hirota, S.; Shima, H. 2008: Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml International Urology and Nephrology 40(1): 85-89
Djavan, B.; Remzi, M.; Zlotta, A.R.; Ravery, V.; Hammerer, P.; Reissigl, A.; Dobronski, P.; Kaisary, A.; Marberger, M. 2002: Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: Results of the prospective multicenter European trial Urology 60(4 Suppl 1): 4-9
Jung, K.; Stephan, C.; Elgeti, U.; Lein, M.; Brux, B.; Kristiansen, G.; Rudolph, B.; Hauptmann, S.; Schnorr, D.; Loening, S.A.; Sinha, P. 2001: Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer? International Journal of Cancer 93(5): 759-765
Garrido, M.M.; Marta, J.é C.; Bernardino, R.M.; Guerra, J.ão.; Fernandes, F.; Pereira, M.H.; Ribeiro, R.; Holdenrieder, S.; Pinheiro, L.ís.C.; Guimarães, J.ão.T. 2022: The Percentage of [-2]Pro-Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and can be Used as Reflex Tests Archives of Pathology and Laboratory Medicine 146(6): 691-700
Caliskan, S. 2017: Diagnostic efficacy of free prostate-specific antigen/total prostate-specific antigen ratio for the diagnosis of prostate cancer in low concentration (≤4 ng/ml) and intermediate levels of total prostate-specific antigen (4.01-10.0 ng/ml) Journal of Cancer Research and Therapeutics 13(2): 279-283
Jung, K.; Stephan, C.; Elgeti, U.; Lein, M.; Brux, B.; Kristiansen, G.; Rudolph, B.; Hauptmann, S.; Schnorr, D.; Loening, S.A.; Sinha, P. 2001: Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 mug/L: Are they useful tools for early detection and screening of prostate cancer? International Journal of Cancer 93(5): 759-765, 1 September
Mitchell, I.D.; Croal, B.L.; Dickie, A.; Cohen, N.P.; Ross, I. 2001: A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer Journal of Urology 165(5): 1549-1553
Stephan, C.; Jung, K.; Schnorr, D.; Lein, M.; Sinha, P.; Loening, S.A. 2002: Re A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer Journal of Urology 167(1): 259-260
Hara, N.; Kasahara, T.; Kawasaki, T.; Bilim, V.; Obara, K.; Takahashi, K.; Tomita, Y. 2002: Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(6): 1794-1799
Horinaga, M.; Nakashima, J.; Ishibashi, M.; Oya, M.; Ohigashi, T.; Marumo, K.; Murai, M. 2002: Clinical value of prostate specific antigen based parameters for the detection of prostate cancer on repeat biopsy: The usefulness of complexed prostate specific antigen adjusted for transition zone volume Journal of Urology 168(3): 986-990